切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2022, Vol. 15 ›› Issue (04) : 285 -290. doi: 10.3877/cma.j.issn.1674-6880.2022.04.004

论著

CHA2DS2-VASc评分在心力衰竭患者血栓栓塞风险预测中的应用
庞慧1, 纵振坤2,(), 郭鹏2, 魏鹏1, 郝林3   
  1. 1. 221009 江苏徐州,徐州市中心医院(南京医科大学徐州临床医学院)心内科
    2. 221002 江苏徐州,徐州医科大学附属医院神经外科
    3. 221009 江苏徐州,徐州市中心医院(南京医科大学徐州临床医学院)泌尿外科
  • 收稿日期:2022-03-05 出版日期:2022-08-31
  • 通信作者: 纵振坤
  • 基金资助:
    江苏省自然科学基金项目(BK20190158); 江苏省第五期"333工程"(BRA2019239); 江苏省第十五批"六大人才高峰"高层次人才项目(WSN270); 江苏省青年医学人才项目(QNRC2016383); 徐州市应用基础项目(KC19026)

Application of the CHA2DS2-VASc score in predicting thromboembolic risk in patients with heart failure

Hui Pang1, Zhenkun Zong2,(), Peng Guo2, Peng Wei1, Lin Hao3   

  1. 1. Department of Cardiology,
    2. Department of Neurosurgery, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
    3. Department of Urinary Surgery, Xuzhou Central Hospital (Xuzhou School of Clinical Medicine of Nanjing Medical University), Xuzhou 221009, China
  • Received:2022-03-05 Published:2022-08-31
  • Corresponding author: Zhenkun Zong
引用本文:

庞慧, 纵振坤, 郭鹏, 魏鹏, 郝林. CHA2DS2-VASc评分在心力衰竭患者血栓栓塞风险预测中的应用[J/OL]. 中华危重症医学杂志(电子版), 2022, 15(04): 285-290.

Hui Pang, Zhenkun Zong, Peng Guo, Peng Wei, Lin Hao. Application of the CHA2DS2-VASc score in predicting thromboembolic risk in patients with heart failure[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2022, 15(04): 285-290.

目的

分析不同纽约心脏协会(NYHA)心功能分级心力衰竭患者的血栓栓塞风险差异及CHA2DS2-VASc评分对于心力衰竭患者血栓栓塞事件的预测价值。

方法

回顾性分析4 360例心力衰竭住院患者的CHA2DS2-VASc评分,根据心功能的受损状况将其分为NYHA Ⅰ级组(1 180例)、NYHA Ⅱ级组(1 168例)、NYHA Ⅲ级组(1 187例)和NYHA Ⅳ级组(825例)。采用Logistic回归模型分析NYHA心功能分级对心力衰竭患者罹患血栓栓塞疾病风险的影响,NYHA心功能分级与CHA2DS2-VASc评分之间的线性相关度用Spearman相关系数表示,采用受试者工作特征(ROC)曲线的曲线下面积(AUC)判定CHA2DS2-VASc评分对于心力衰竭患者发生血栓栓塞风险的预测价值。

结果

4组患者间年龄(F = 106.490,P<0.001)、女性(H = 79.101,P< 0.001)、年龄亚组(H = 256.557,P<0.001)、高血压(H = 8.092,P = 0.044)、糖尿病(H = 8.060,P = 0.045)、血栓栓塞疾病(H = 41.427,P<0.001)、血管疾病(H = 40.567,P < 0.001)、高脂血症(H = 260.762,P < 0.001)及心房颤动(H = 306.597,P < 0.001)比例的比较,差异均有统计学意义。且与NYHA Ⅰ级组比较,女性比例,NYHA Ⅱ~Ⅳ级组患者中65~74岁与≥ 75岁比例,以及患糖尿病、血栓栓塞疾病、血管疾病、心房颤动比例均显著升高(P均< 0.05)。Logistic回归模型校正危险因素后发现,NYHA Ⅲ级[比值比(OR)=1.500,95%置信区间(CI)(1.126,1.999),P = 0.006]与NYHA Ⅳ级[OR = 1.688,95%CI(1.239,2.300),P = 0.001]均是心力衰竭患者发生血栓栓塞的独立危险因素。心功能级别与CHA2DS2-VASc评分两变量之间呈弱相关(r = 0.193,P < 0.001)。ROC曲线分析结果显示CHA2DS2-VASc评分[AUC = 0.902,95%CI(0.890,0.915),P < 0.001]对于心力衰竭患者血栓栓塞风险的预测价值较高。

结论

心力衰竭患者NYHA心功能分级越高,血栓栓塞风险越高。合并血栓栓塞高危因素时,可采用CHA2DS2-VASc评分系统评估栓塞风险的同时给予恰当的抗凝治疗,降低栓塞事件发生率。

Objective

To analyze the differences in thromboembolic risk among patients with heart failure in different New York Heart Association (NYHA) classifications and the value of CHA2DS2-VASc score in predicting thromboembolism.

Methods

The CHA2DS2-VASc scores of 4 360 inpatients with heart failure were analyzed retrospectively. They were divided into four groups, including NYHA class Ⅰ group (1 180 cases), NYHA class Ⅱ group (1 168 cases), NYHA class Ⅲ group (1 187 cases) and NYHA class Ⅳ group (825 cases), based on the impairment of cardiac function. The Logistic regression model was used to analyze the association between NYHA classification and thromboembolic risk in patients with heart failure. The linear correlation between NYHA classification and CHA2DS2-VASc score was described using Spearman correlation coefficient. The predictive value of CHA2DS2-VASc score for the risk of thromboembolism in patients with heart failure was determined by the area under the receiver operating characteristic (ROC) curve (AUC).

Results

The age (F = 106.490, P < 0.001), female (H = 79.101, P < 0.001), age subgroup (H = 256.557, P < 0.001), hypertension (H = 8.092, P = 0.044), diabetes mellitus (H = 8.060, P = 0.045), thromboembolic disease (H = 41.427, P < 0.001), vascular disease (H = 40.567, P < 0.001), hyperlipidemia (H = 260.762, P < 0.001) and atrial fibrillation (H = 306.597, P < 0.001) among the four groups all showed significant differences. In comparison with the NYHA class Ⅰ group, the NYHA class Ⅱ- Ⅳ groups had higher proportions of female, higher rate ratios for age 65 - 74 subgroup and ≥ 75 subgroup, and higher prevalence of diabetes mellitus, thromboembolism, vascular disease and atrial fibrillation (all P < 0.05). The Logistic regression analysis showed that NYHA class Ⅲ [odds ratio (OR) = 1.500, 95% confidence interval (CI) (1.126, 1.999), P = 0.006] and NYHA class Ⅳ [OR = 1.688, 95%CI (1.239, 2.300), P = 0.001] were independent risk factors for thromboembolism in patients with heart failure, after adjustment for risk factors. The NYHA classification was weakly positively correlated with the CHA2DS2-VASc score (r = 0.193, P < 0.001). The ROC result revealed that the predictive value of CHA2DS2-VASc score [AUC = 0.902, 95%CI (0.890, 0.915), P < 0.001] was excellent in thromboembolic risk among patients with heart failure.

Conclusions

In patients with heart failure, a higher grade of NHYA functional classification appears to confer a higher risk of thromboembolism. We can assess eligibility for anticoagulation using the CHA2DS2-VASc score in heart failure patients at high risk of thromboembolism to reduce the incidence of thromboembolic events.

表1 不同心功能级别心力衰竭患者基线资料比较[例(%)]
表2 不同心功能级别对心力衰竭患者血栓栓塞患病率影响的Logistic回归分析
表3 CHA2DS2-VASc评分预测不同心功能级别心力衰竭患者血栓栓塞风险的ROC曲线分析
1
Writing Committee, Maddox TM, Januzzi JL Jr, et al. 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee[J]. J Am Coll Cardiol, 2021, 77 (6): 772-810.
2
Müller-Tasch T, Lowe B, Lossnitzer N, et al. Anxiety and self-care behaviour in patients with chronic systolic heart failure: a multivariate model[J]. Eur J Cardiovasc Nurs, 2018, 17 (2): 170-177.
3
Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry[J]. Eur J Heart Fail, 2017, 19 (12): 1574-1585.
4
中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.慢性心力衰竭基层诊疗指南(2019年)[J].中华全科医师杂志201918(10):936-947.
5
Chaplin S. Chronic heart failure in adults: diagnosis and management[J]. Prescriber, 2019, 30 (1): 16-18.
6
中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志201442(2):98-122.
7
Chiang CE, Okumura K, Zhang S, et al. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation[J]. J Arrhythm, 2017, 33 (4): 345-367.
8
中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志201846(10):760-789.
9
国家卫生计生委合理用药专家委员会,中国药师协会.心力衰竭合理用药指南(第2版)[J/CD].中国医学前沿杂志(电子版)201911(7):1-78.
10
Shoemaker MJ, Dias KJ, Lefebvre KM, et al. Physical therapist clinical practice guideline for the management of individuals with heart failure[J]. Phys Ther, 2020, 100 (1): 14-43.
11
中国医师协会心血管内科医师分会,中国心血管健康联盟,心肌梗死后心力衰竭防治专家共识工作组. 2020心肌梗死后心力衰竭防治专家共识[J].中国循环杂志202035(12):1166-1180.
12
Ikonomidis I, Aboyans V, Blacher J, et al. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association[J]. Eur J Heart Fail, 2019, 21 (4): 402-424.
13
Jaarsma T, Hill L, Bayes-Genis A, et al. Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart Fail, 202123 (1): 157-174.
14
Zannad F, Anker SD, Byra WM, et al. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease[J]. N Engl J Med, 2018, 379 (14): 1332-1342.
15
Mehra MR, Vaduganathan M, Fu M, et al. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial[J]. Eur Heart J, 2019, 40 (44): 3593-3602.
16
Greenberg B, Neaton JD, Anker SD, et al. Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial[J]. JAMA Cardiol, 2019, 4 (6): 515-523.
17
国家卫生健康委员会脑卒中防治专家委员会房颤卒中防治专业委员会,中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会.中国心源性卒中防治指南(2019)[J].中华心律失常学杂志201923(6):463-484.
18
Obeidat M, Burgess M, Lip GYH. Atrial fibrillation in heart failure: focus on antithrombotic management[J]. Heart Fail Clin, 2020, 16 (1): 107-120.
19
Farmakis D, Chrysohoou C, Giamouzis G, et al. The management of atrial fibrillation in heart failure: an expert panel consensus[J]. Heart Fail Rev, 2021, 26 (6): 1345-1358.
20
黄从新,张澍,黄德嘉,等.心房颤动:目前的认识和治疗的建议-2018[J].中国心脏起搏与电生理杂志201832(4):315-368.
[1] 张胜男, 苗雅敬, 周虹, 韩高洁, 王静, 仝巧立, 张旭倩, 尹洪宁. 左心耳三维经食管超声测量与Watchman左心耳封堵器大小的相关性研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(02): 107-113.
[2] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[3] 姚金含, 王伟娜, 张玉泉. 妊娠相关深静脉血栓形成患者的预后研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 367-373.
[4] 李国煜, 丛赟, 祖丽胡马尔·麦麦提艾力, 何铁英. 急性胰腺炎并发门静脉系统血栓形成的危险因素及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 266-270.
[5] 陈杨, 李茜, 杨中华. 慢性阻塞性肺疾病急性加重期合并VTE抗凝治疗的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 316-319.
[6] 于洁, 金小红, 顾艳楣, 王慧, 葛杨杨, 李燕. 癌症相关静脉血栓栓塞症患者疾病体验与需求的质性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 739-744.
[7] 彭小蓉, 莫伟, 李琴, 吴雅琴, 李兰. 妊娠期妇女静脉血栓栓塞症预防的知信行现状及其影响因素分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 274-280.
[8] 黄淑萍, 龚蓓, 申铁梅, 杨丹莉, 陈秀梅, 李国琪, 李星, 麦爱欢, 钟冰, 广东省护士协会心血管疾病护理分会, 南方心血管护理联盟. 心房颤动患者介入手术围术期护理专家共识[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 1-9.
[9] 付明鹏, 牛国栋, 岑志富, 乔宇, 郭金锐, 郭雨龙, 谢阳, 刘晨, 袁华苑, 刘可, 何姗姗. 三维标测系统指导下国产花瓣状脉冲电场消融系统应用一例[J/OL]. 中华心脏与心律电子杂志, 2024, 12(03): 180-184.
[10] 李云峰, 周世强, 李飞. 心力衰竭器械治疗新进展[J/OL]. 中华心脏与心律电子杂志, 2024, 12(02): 113-118.
[11] 米娜瓦尔·阿不都克力木, 董吁钢, 刘晨, 薛睿聪. 氯苯唑酸治疗野生型转甲状腺素蛋白心脏淀粉样变一例[J/OL]. 中华心脏与心律电子杂志, 2024, 12(02): 119-122.
[12] 曹婧然, 董福强, 张立剑, 刘长乐, 张煜坤, 陈康寅. 老年冠心病患者的营养风险、肌少症和衰弱筛查分析[J/OL]. 中华老年病研究电子杂志, 2024, 11(02): 5-9.
[13] 文明, 张丽, 谢芳, 艾克拜尔·艾力, 克力木·阿不都热依木. 构建胃食管反流病患者发生心房颤动的临床预测模型[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 130-136.
[14] 郑屹, 刘莹, 张煜坤, 李广平, 陈康寅, 刘彤. 既往及新发心房颤动对急性心肌梗死患者远期卒中风险的影响[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 406-417.
[15] 李芳, 戴西望, 王凯, 郭廷昊, 涂江龙. 非瓣膜性心房颤动相关性卒中的治疗研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 393-397.
阅读次数
全文


摘要